BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31976031)

  • 1. Berberine Attenuates Hyperglycemia by Inhibiting the Hepatic Glucagon Pathway in Diabetic Mice.
    Zhong Y; Jin J; Liu P; Song Y; Zhang H; Sheng L; Zhou H; Jiang B
    Oxid Med Cell Longev; 2020; 2020():6210526. PubMed ID: 31976031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Berberine improves glucose metabolism in diabetic rats by inhibition of hepatic gluconeogenesis.
    Xia X; Yan J; Shen Y; Tang K; Yin J; Zhang Y; Yang D; Liang H; Ye J; Weng J
    PLoS One; 2011 Feb; 6(2):e16556. PubMed ID: 21304897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Hypoglycemic Effect of Berberine and Berberrubine Involves Modulation of Intestinal Farnesoid X Receptor Signaling Pathway and Inhibition of Hepatic Gluconeogenesis.
    Sun R; Kong B; Yang N; Cao B; Feng D; Yu X; Ge C; Feng S; Fei F; Huang J; Lu Z; Xie Y; Yang CS; Guo GL; Wang G; Aa J
    Drug Metab Dispos; 2021 Mar; 49(3):276-286. PubMed ID: 33376148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Berberine ameliorates glucocorticoid-induced hyperglycemia: an in vitro and in vivo study.
    Gupta M; Rumman M; Singh B; Mahdi AA; Pandey S
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Mar; 397(3):1647-1658. PubMed ID: 37704773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Berberine Improves Inflammatory Responses of Diabetes Mellitus in Zucker Diabetic Fatty Rats and Insulin-Resistant HepG2 Cells through the PPM1B Pathway.
    Wu YS; Li ZM; Chen YT; Dai SJ; Zhou XJ; Yang YX; Lou JS; Ji LT; Bao YT; Xuan L; Lin LN; Li CY
    J Immunol Res; 2020; 2020():2141508. PubMed ID: 32908938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Berberine alleviates hyperglycemia by targeting hepatic glucokinase in diabetic db/db mice.
    Li M; Dang Y; Li Q; Zhou W; Zuo J; Yao Z; Zhang L; Ji G
    Sci Rep; 2019 May; 9(1):8003. PubMed ID: 31142783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Berberine promotes glucose uptake and inhibits gluconeogenesis by inhibiting deacetylase SIRT3.
    Zhang B; Pan Y; Xu L; Tang D; Dorfman RG; Zhou Q; Yin Y; Li Y; Zhou L; Zhao S; Zou X; Wang L; Zhang M
    Endocrine; 2018 Dec; 62(3):576-587. PubMed ID: 30117113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Berberine inhibits hepatic gluconeogenesis via the LKB1-AMPK-TORC2 signaling pathway in streptozotocin-induced diabetic rats.
    Jiang SJ; Dong H; Li JB; Xu LJ; Zou X; Wang KF; Lu FE; Yi P
    World J Gastroenterol; 2015 Jul; 21(25):7777-85. PubMed ID: 26167077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Berberine Attenuates Development of the Hepatic Gluconeogenesis and Lipid Metabolism Disorder in Type 2 Diabetic Mice and in Palmitate-Incubated HepG2 Cells through Suppression of the HNF-4α miR122 Pathway.
    Wei S; Zhang M; Yu Y; Lan X; Yao F; Yan X; Chen L; Hatch GM
    PLoS One; 2016; 11(3):e0152097. PubMed ID: 27011261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulated TGF-β1 contributes to hyperglycaemia in type 2 diabetes by potentiating glucagon signalling.
    Xiao Y; Wang Y; Ryu J; Liu W; Zou H; Zhang R; Yan Y; Dai Z; Zhang D; Sun LZ; Liu F; Zhou Z; Dong LQ
    Diabetologia; 2023 Jun; 66(6):1142-1155. PubMed ID: 36917279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small Hepatitis B Virus Surface Antigen Promotes Hepatic Gluconeogenesis via Enhancing Glucagon/cAMP/Protein Kinase A/CREB Signaling.
    Chen Y; Wang B; Ou X; Wu Y; He Y; Lin X; Lin X
    J Virol; 2022 Dec; 96(23):e0102022. PubMed ID: 36394315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIF2α Is an Essential Molecular Brake for Postprandial Hepatic Glucagon Response Independent of Insulin Signaling.
    Ramakrishnan SK; Zhang H; Takahashi S; Centofanti B; Periyasamy S; Weisz K; Chen Z; Uhler MD; Rui L; Gonzalez FJ; Shah YM
    Cell Metab; 2016 Mar; 23(3):505-16. PubMed ID: 26853750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Berberine ameliorates hyperglycemia in alloxan-induced diabetic C57BL/6 mice through activation of Akt signaling pathway.
    Xie X; Li W; Lan T; Liu W; Peng J; Huang K; Huang J; Shen X; Liu P; Huang H
    Endocr J; 2011; 58(9):761-8. PubMed ID: 21705841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. cAMP-responsive element-binding protein (CREB)-regulated transcription coactivator 2 (CRTC2) promotes glucagon clearance and hepatic amino acid catabolism to regulate glucose homeostasis.
    Erion DM; Kotas ME; McGlashon J; Yonemitsu S; Hsiao JJ; Nagai Y; Iwasaki T; Murray SF; Bhanot S; Cline GW; Samuel VT; Shulman GI; Gillum MP
    J Biol Chem; 2013 May; 288(22):16167-76. PubMed ID: 23595987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Berberine ameliorates diabetic nephropathy by inhibiting TLR4/NF-κB pathway.
    Zhu L; Han J; Yuan R; Xue L; Pang W
    Biol Res; 2018 Mar; 51(1):9. PubMed ID: 29604956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic TRAF2 regulates glucose metabolism through enhancing glucagon responses.
    Chen Z; Sheng L; Shen H; Zhao Y; Wang S; Brink R; Rui L
    Diabetes; 2012 Mar; 61(3):566-73. PubMed ID: 22315325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic role in an early glucose-lowering effect by a novel dipeptidyl peptidase 4 inhibitor, evogliptin, in a rodent model of type 2 diabetes.
    Kim TH; Kim MK; Cheong YH; Chae YN; Lee Y; Ka SO; Jung IH; Shin CY; Bae EJ; Son MH
    Eur J Pharmacol; 2016 Jan; 771():65-76. PubMed ID: 26621343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Berberine inhibits gluconeogenesis in spontaneous diabetic rats by regulating the AKT/MAPK/NO/cGMP/PKG signaling pathway.
    Lu M; Wang Y; Jiang Y; Zhang C; Wang H; Sha W; Chen L; Lei T; Liu L
    Mol Cell Biochem; 2023 Sep; 478(9):2013-2027. PubMed ID: 36598615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of berberine on the renal tubular epithelial-to-mesenchymal transition by inhibition of the Notch/snail pathway in diabetic nephropathy model KKAy mice.
    Yang G; Zhao Z; Zhang X; Wu A; Huang Y; Miao Y; Yang M
    Drug Des Devel Ther; 2017; 11():1065-1079. PubMed ID: 28408805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GLP-1(28-36) improves β-cell mass and glucose disposal in streptozotocin-induced diabetic mice and activates cAMP/PKA/β-catenin signaling in β-cells in vitro.
    Shao W; Wang Z; Ip W; Chiang YT; Xiong X; Chai T; Xu C; Wang Q; Jin T
    Am J Physiol Endocrinol Metab; 2013 Jun; 304(12):E1263-72. PubMed ID: 23571712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.